Advertisement
ANI Pharma Guides FY23 Adj. EPS Below Estimates, But Revenues Above - Update
(RTTNews) - While reporting financial results for the fourth quarter on Thursday, biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) initiates adjusted earnings and net revenue guidance for the full-year 2023.
For fiscal 2023, the company now projects adjusted earnings in a range of $2.09 to $2.59 per share on net revenues between $360 million and $385 million, with purified cortrophin gel revenue at $80 million to $90 million.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.62 per share on revenues of $352.49 million for the year. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
ANI Pharma Launches Kionex Suspension For Oral Or Rectal Use
Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) announced Monday the launch of Kionex (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use.
RTTNews
|
366 hari yang lalu
ANI Pharma Says FDA Approves Methsuximide Capsules, Alendronate Sodium Oral Solution
ANI Pharmaceuticals, Inc. (ANIP) announced Monday that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Applications (ANDAs) for Methsuximide Capsules USP, 300 mg and Alendronate Sodium Oral Solution 70 mg (base)/75 mL.
RTTNews
|
737 hari yang lalu
ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets
ANI Pharmaceuticals, Inc. (ANIP) announced Wednesday that it has received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Clorazepate Dipotassium Tablets.
RTTNews
|
1064 hari yang lalu
Pound Advances After U.K. Inflation Data
The pound was higher against its major counterparts in the New York session on Wednesday, after data showing an acceleration in consumer price inflation in the month of April.
RTTNews
|
36 minit yang lalu
Canadian Market Turns Weak, Set To Snap 10-session Winning Streak
After ten straight days of gains, the Canadian market is down in negative territory Wednesday afternoon, weighed down by losses in healthcare, technology, real estate and consumer discretionary sectors.
RTTNews
|
1j 35min yang lalu
Swiss Markets Ends Modestly Lower
The Switzerland market ended lower on Wednesday after languishing in negative territory right through the day's trading session, as concerns about trade and geopolitical uncertainty rendered the mood cautious, prompting investors to refrain from making significant moves.
RTTNews
|
2j 16min yang lalu
European Stocks Close On Mixed Note Amid Geopolitical, Trade Uncertainty
European stocks turned in a mixed performance on Wednesday after a cautious session as investors awaited clarity on the trade front. The impasse in Ukraine peace talks and data showing a bigger than expected increase in UK inflation weighed on sentiment.
A downward revision in U.S. federal deficit weighed as well.
RTTNews
|
2j 53min yang lalu
Bay Street Seen Opening On Mixed Note
Canadian shares are likely to open on a mixed note Wednesday morning. Weak European stocks, concerns about U.S. debt, impasse over peace talks and a lack of progress in trade negotiations may weigh on sentiment.
Firm bullion and crude oil prices could trigger buying in resources sectors and limit market's downside.
RTTNews
|
7j 34min yang lalu
